Catalyst Wire Dossier Catalyst Wire Dossier

EDURANT PED

rilpivirine hydrochloride · Janssen Products, LP
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EDURANT PED, covering 2024-03-15 to 2024-03-15. Get the full timeline:

Most recent: FDA Approved: EDURANT PED — Original Application (Janssen Products, LP)

See pricing